Epidermal growth factor receptor in tumor angiogenesis.

Epidermal growth factor receptor in tumor angiogenesis.

Hematology/oncology clinics of North America (2004-10-12)

Lee M Ellis

RÉSUMÉ

This article focuses on the preclinical evidence for activation of the epidermal growth factor receptor (EGFR) in promoting angiogenesis and the efficacy of anti-EGFR agents in inhibiting angiogenesis and tumor growth.

MATÉRIAUX

Référence du produit

Marque

Description du produit

V5765

Sigma-Aldrich

VEGF165, recombinant, expressed in HEK 293 cells, suitable for cell culture